Comparative Study Of Injection Triamcinolone And Hyaluronidase Combination With Injection Platelet Rich Plasma (PRP) In Management Of Oral Submucous Fibrosis
DOI:
https://doi.org/10.69980/ajpr.v28i4.291Abstract
Introduction: Oral sub mucous fibrosis (OSMF) is an oral precancerous condition and chances of transformation in to malignancy is 1.5-15%. It is characterized by inflammation and progressive fibrosis of the submucosal tissue resulting in marked rigidity and trismus.
Objective: The objective of this study aimed to compare the results of Injection Triamcinolone and Hyaluronidase Combination with Injection Platelet Rich Plasma (PRP)in the management of oral submucous fibrosis. Methodology: This comparative study was conducted at Bolan Medical Complex Hospital quetta and Bakhtawar Amin Medical and Dental College duration 2022 Jan to September 2024. Patients in group A received a combination of triamcinolone and Hyaluronidase in group B PRP (platelets rich plasma) injected intralesionally in fibrosis of OSMF, once a week.
Results: Data were collected from 60 patients with mean age of patients in both groups was similar, with 42.5 ± 9.3 years in Group A and 41.8 ± 8.7 years in Group B. The duration of symptoms was slightly longer in Group A (3.8 ± 1.5 years) compared to Group B (3.6 ± 1.7 years), though not significantly different. Group A (Triamcinolone + Hyaluronidase) saw a reduction in the baseline pain score from 7.2 to 3.1, representing a 56.9% decrease in pain. Group B (PRP), however, exhibited a more pronounced reduction, with pain scores dropping from 7.0 to 1.9, resulting in a 72.9% decrease.
Conclusion: It is concluded that Injection Platelet Rich Plasma (PRP) is a more effective and safer treatment option than the combination of Triamcinolone and Hyaluronidase for managing Oral Submucous Fibrosis (OSMF). PRP demonstrated superior outcomes in improving mouth opening, reducing pain, and enhancing patient satisfaction, with fewer side effects and lower recurrence rates.
References
1. Ray, J.G., Ranganathan, K. and Chattopadhyay, A., 2016. Malignant transformation of oral submucous fibrosis: Overview of histopathological aspects. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 122, pp.200–209.
2. Chattopadhyay, A. and Ray, J.G., 2016. Molecular pathology of malignant transformation of oral submucous fibrosis. Journal of Environmental Pathology, Toxicology and Oncology, 35, pp.193–205.
3. Rajendran, R., 1994. Oral submucous fibrosis: etiology, pathogenesis and future research. Bulletin of the World Health Organization, 72(6), pp.986–996.
4. Murti, P.R., Bhonsle, R.B., Gupta, P.C., Daftary, D.K., Pindborg, J.J. and Mehta, F.S., 1995. Etiology of oral submucous fibrosis with special reference to the role of areca nut chewing. Journal of Oral Pathology and Medicine, 24(4), pp.145–152.
5. Babu, S., Bhat, R.V. and Kumar, P.U., 1996. A comparative clinico-pathological study of oral submucous fibrosis in habitual chewers of pan masala and betel quid. Clinical Toxicology, 34, pp.317–322.
6. Auluck, A., Rosin, M.P. and Zhang, L., 2008. Oral submucous fibrosis; a clinically benign but potentially malignant disease: Report of 3 cases and review of literature. Journal of the Canadian Dental Association, 74(8), p.735. Available at: http://www.cda-adc.ca/jcda/vol-74/issue-8/735.html [Accessed 18 September 2024].
7. Chole, R.H., Gondivkar, S.M., Gadbail, A.R., Balsaraf, S., Chaudhary, S. and Dhore, S.V., 2012. Review of drug treatment of oral submucous fibrosis. Oral Oncology, 48, pp.393–398.
8. Pandya, S., Chaudhary, A.K., Singh, M., Singh, M. and Mehrotra, R., 2009. Correlation of histopathological diagnosis with habits and clinical findings in oral submucous fibrosis. Head and Neck Oncology, 1, p.10.
9. Ceena, D.E., Bastian, T.S., Ashok, L. and Annigeri, R.G., 2009. Comparative study of clinic functional staging of oral submucous fibrosis with qualitative analysis of collagen fibers under polarizing microscopy. Indian Journal of Dental Research, 20(3), pp.271–276.
10. Patil, S. and Maheshwari, S., 2014. Proposed new grading of oral submucous fibrosis based on cheek flexibility. Journal of Clinical and Experimental Dentistry, 6(3), pp.e255–e258.
11. Gupta, M., Pachauri, A., Singh, S.K., Ahuja, R., Singh, P. and Mishra, S.S.S., 2014. Recent advancements in oral submucous fibrosis management: An overview. Bangladesh Journal of Dental Research & Education, 4(2), pp.88–90.
12. Albanese, A., Licata, M.E., Polizzi, B. and Campisi, G., 2013. Platelet-rich plasma (PRP) in dental and oral surgery: from the wound healing to bone regeneration. Immunity & Ageing, 10(1), p.23.
13. Lin, S.L., Tsai, C.C., Wu, S.L., Ko, S.Y., Chiang, W.F. and Yang, J.W., 2018. Effect of athrocentesis plus platelet-rich plasma and platelet-rich plasma alone in the treatment of temporomandibular joint osteoarthritis: A retrospective matched cohort study. Medicine, 97(16), p.e0477.
14. Marx, R.E., 2004. Platelet-rich plasma: evidence to support its use. Journal of Oral and Maxillofacial Surgery, 62, pp.489–496.
15. Dyavanagoudar, S.N., 2009. Oral submucous fibrosis: Review on etiopathogenesis. Journal of Cancer Science & Therapy, 1, pp.72–77. doi:10.4172/1948-5956.1000011.
16. Yoithapprabhunath, T.R., Maheswaran, T., Dineshshankar, J., Anusushanth, A., Sindhuja, P. and Sitra, G., 2013. Pathogenesis and therapeutic intervention of oral submucous fibrosis. Journal of Pharmacy & Bioallied Sciences, 5(Suppl 1), pp.S85–S88.
17. Chole, R.H. and Patil, R., 2016. Drug treatment of oral submucous fibrosis – a review. International Journal of Contemporary Medical Research, 3(4), pp.996–998.
18. James, L., Shetty, A., Rishi, D. and Abraham, M., 2015. Management of oral submucous fibrosis with injection of hyaluronidase and dexamethasone in grade III oral submucous fibrosis: A retrospective study. Journal of International Oral Health, 7(8), pp.82–85.
19. Gupta, J., Srinivasan, S.V. and Jonathan, D.M., 2012. Efficacy of betamethasone, placental extract and hyaluronidase in the treatment of OSMF: A comparative study. e-Journal of Dentistry, 2(1). Available at:
https://www.ejournalofdentistry.com [Accessed 18 September 2024].
20. Yadav, M., Aravinda, K., Saxena, V.S., Srinivas, K., Ratnakar, P., Gupta, J., Sachdev, A.S. and Shivhare, P., 2014. Comparison of curcumin with intralesional steroid injections in oral submucous fibrosis – A randomized, open-label interventional study. Journal of Oral Biology and Craniofacial Research, 4(3), pp.169–173.
21. Shaikh, A.H., Ahmed, S., Siddique, S., Iqbal, N., Hasan, S.M.U., Zaidi, S.J.A. and Ali, A., 2019. Oral submucous fibrosis; study of cases reported at Dow international medical college hospital in Karachi, Pakistan. Professional Medical Journal, 26(2), pp.275–281.
22. Hazarey, V.K., Erlewad, M., Mundhe, K.A. and Ughade, S.N., 2007. Oral submucous fibrosis: study of 1000 cases from central India. Journal of Oral Pathology & Medicine, 36, pp.12–17.
23. Naik, S.M., Appaji, M.K., Ravishankara, S., Goutham, M.K., Devi, N.P., Mushannavar, A.S. and Naik, S.S., 2012. Comparative study of intralesional Triamcinolone Acetonide & hyaluronidase vs placental extract in 60 cases of oral submucous fibrosis. International Journal of Head and Neck Surgery, 3(2), pp.59–65.
24. Patel, T.L. and Singh, S., 2015. Comparative evaluation of treatment of oral submucous fibrosis with intralesional injections of dexamethasone and hyaluronidase with Triamcinolone Acetonide and hyaluronidase. Journal of Contemporary Medicine and Dentistry, 3(3), pp.32–34.
25. Daga, D., Singh, R.K., Pal, U.S., Gurung, T. and Gangwar, S., 2017. Efficacy of oral colchicine with intralesional hyaluronidase or triamcinolone acetonide in the Grade II oral submucous fibrosis. National Journal of Maxillofacial Surgery, 8(1), pp.50–54. doi:10.4103/njms.NJMS_5_17
Downloads
Published
Issue
Section
License
Copyright (c) 2025 American Journal of Psychiatric Rehabilitation
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License permitting all use, distribution, and reproduction in any medium, provided the work is properly cited.
